Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis have?
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis has 604 citations in the OpenAlex counts ScholarIQ stores.
When was Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis published?
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis has 2017 year in the ScholarIQ index.
What is the open-access status of Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis?
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis has green oa status in the ScholarIQ index.
What is the DOI of Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis?
The DOI for Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis is on the source record.
What is the PMID of Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis?
The PMID for Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis is on the source record.
What is the OpenAlex record for Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis?
The OpenAlex for Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis is on the source record.